| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | XBRANE BIOPHARMA AB (PUBL) | 1.02% | 1.42% | -24.43% | -37.04% | 111.76% | 198 |
| | | | | | | |
 | MODERNA, INC. | -2.49% | 10.15% | -44.95% | -15.76% | 518.63% | 57 031 |
 | LONZA GROUP AG | 3.71% | 0.38% | -27.31% | -2.50% | 78.29% | 40 761 |
| IQVIA HOLDINGS INC. | 0.17% | -0.39% | -28.37% | -14.64% | 51.19% | 38 185 |
| SEAGEN INC. | -0.97% | 12.22% | -8.64% | -9.06% | 119.40% | 26 255 |
| ICON PUBLIC LIMITED COMPANY | 0.91% | 3.65% | -30.19% | -6.42% | 57.49% | 17 418 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.48% | 6.55% | -22.59% | -6.30% | 99.32% | 15 628 |
 | CELLTRION, INC. | -1.05% | -2.76% | -28.79% | -47.13% | -21.21% | 15 388 |
| BIO-TECHNE CORPORATION | 0.73% | 5.03% | -28.65% | -9.72% | 86.95% | 14 377 |
 | PHARMARON BEIJING CO., LTD. | -1.42% | -3.62% | -21.80% | -34.98% | 212.86% | 12 310 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1.05% | 2.23% | -37.84% | -28.31% | 81.94% | 11 775 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | -0.62% | -4.10% | -33.66% | -48.20% | 82.24% | 10 526 |
| QIAGEN N.V. | 1.98% | 0.41% | -18.44% | -6.73% | 19.26% | 10 110 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.12% | 0.32% | 2.47% | 86.80% | 128.88% | 10 021 |
| UNITED THERAPEUTICS CORPORATION | 0.66% | 2.72% | -13.21% | -1.86% | 113.35% | 8 440 |
| SYNEOS HEALTH, INC. | 1.40% | 1.74% | -31.10% | -18.37% | 70.44% | 7 157 |
| | | | | | | |
| | Durchschnitt | 0.38% | 2.30% | -24.87% | -10.88% | 113.27% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.16% | 3.65% | -28.05% | -11.81% | 164.99% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
